Multiple eccrine spiradenoma in zosteriform distribution [14]

Altinyazar H.C. | Kargi E. | Özen Ö. | Koca R. | Babucçu O.

Letter | 2003 | Plastic and Reconstructive Surgery112 ( 3 ) , pp.927 - 928

[No abstract available]

A Training Model for Cutaneous Surgery

Altinyazar H.C. | Hosnuter M. | Ünalacak M. | Koca R. | Babucçu O.

Article | 2003 | Dermatologic Surgery29 ( 11 ) , pp.1122 - 1124

BACKGROUND. Training models are necessary for development of many skills in medical education. OBJECTIVE. To develop a training model for improvement of simple surgical procedure skills. METHODS. A convex, rectangular, smooth-surfaced wooden plate covered by first cotton material and then polyethylene stretch film was used. Skins of rats that had been used previously for experimental studies were attached on the wooden plate. In order to see efficacy of our model, we decided to use it in a cutaneous surgery workshop. Theoretical and practical information about surgical sutures, punch biopsy, excisional biopsy, rotational flap, and Z . . .-plasty procedures was given to the participant physicians. Surgical skills of participants were scored before and after the practical part of workshop. RESULTS. Thirty-three physicians were enrolled voluntarily to the workshop. All participants showed statistically significant increase in scores (P < 0.05). CONCLUSION. The similarity to human skin and the easy setup make this training model an ideal teaching tool to improve the skills of physicians for simple cutaneous surgery Daha fazlası Daha az

Is topical metronidazole effective in seborrheic dermatitis? A double-blind study

Koca R. | Altinyazar H.C. | Eştürk E.

Conference Object | 2003 | International Journal of Dermatology42 ( 8 ) , pp.632 - 635

Background: Seborrheic dermatitis is a common, chronic, papulosquamous dermatosis. Although several types of treatment have been developed, repetitive treatment courses are often necessary. Aim: To perform a randomized, placebo-controlled, double-blind clinical study with metronidazole 0.75% gel in patients with mild to moderate seborrheic dermatitis of the face. Methods: Eighty-four patients (52 males and 32 females) with seborrheic dermatitis were enrolled in the study. Patients were randomly allocated to the application of metronidazole 0.75% gel or placebo to their facial lesions, twice daily for 8 weeks. Patients were scored wi . . .th regard to the severity of the lesions at the initial evaluation and every 2 weeks for 2 months. All patients were evaluated for a final assessment of improvement at the end of the study. Results: At baseline, both treatment groups were comparable in terms of demographic data and lesion severity score. Seventy-eight patients (48 males and 30 females), 48 (62%) in the metronidazole group and 30 (38%) in the placebo group, completed the study. Two patients in the metronidazole group and four patients in the placebo group left the study. There was no statistically significant difference in the change in the mean severity score between the two groups at the end of the study (P > 0.05). At the final evaluation of the response at 8 weeks, no statistically significant difference was found between the treatment groups (P > 0.05). Metronidazole gel was generally tolerated well during the study. Conclusions: Metronidazole 0.75% gel and placebo show similar efficacy in the treatment of seborrheic dermatitis Daha fazlası Daha az

Nevus comedonicus [13]

Kargi E. | Koca R. | Şahin D.A. | Akin A.

Letter | 2003 | Plastic and Reconstructive Surgery112 ( 4 ) , pp.1183 - 1185

[No abstract available]

Psoriasiform drug eruption associated with metformin hydrochloride: A case report

Koca R. | Altinyazar H.C. | Yenidünya S. | Tekin N.S.

Article | 2003 | Dermatology Online Journal9 ( 3 ) , pp.134 - 139

An 18 year-old-woman presented with a 1-week history of a psoriasiform eruption on her limbs and trunk that began 1 week after starting metformin hydrochloride. She had taken no other medications. She had no personal or family history of psoriasis. The lesions disappeared within 5 weeks after discontinuation of the drug. In the 4 months following the cessation of metformin hydrochloride, no relapse was observed, but rechallenge with oral metformin again produced the eruption. Metformin hydrochloride should be added to the list of drugs that can cause a psoriasiform eruption.

6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.